TASOS

Η Pharmathen εξαγοράζει την CBL Patras

Συνέργειες μέσω καθετοποίησης και ολοκληρωμένη δημιουργία χαρτοφυλακίου προϊόντων και υπηρεσιών που περιλαμβάνουν πρώτες ύλες, πεπτίδια και τελικά φαρμακευτικά προϊόντα. Ολοκληρωμένη εμπειρία πελάτη, που βασίζεται σε σταθερά πρότυπα υψηλής ποιότητας, και ολιστική υποστήριξη των πελατών σε όλες τις κατηγορίες προϊόντων. Ενίσχυση της φήμης της Ελλάδας ως ενός ταχέως αναπτυσσόμενου και δυναμικού κόμβου καινοτόμων φαρμακευτικών προϊόντων.  Αθήνα, […]

Η Pharmathen εξαγοράζει την CBL Patras Read More »

Boulder Peptide Society 9/21-24 | 2020 Boulder, Colorado (Founding Sponsor)

The Boulder Peptide Symposium will take place in Sep 21-24 | 2020 at Boulder Colorado. CBL is a founding sponsor of this symposium. The 2020 Boulder Peptide Symposium once again brings together thought leaders in biotech, pharma, and academic institutions to present current paradigms in peptide therapeutics and to uncover solutions to challenges in peptide

Boulder Peptide Society 9/21-24 | 2020 Boulder, Colorado (Founding Sponsor) Read More »

CPhI North America, May 5 – 7, 2020 ,Philadelphia

CPhI North America will take place in May 5 – 7, 2020 in Philadelphia CPhI North America Pharma industry leaders gather annually at CPhI North America to discuss pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs as well as advancements in bio-manufacturing. source: https://cphinorthamerica.com/

CPhI North America, May 5 – 7, 2020 ,Philadelphia Read More »

DCAT  March 23-26, 2020, New York City

DCAT Week will take place in March 23-26, 2020 in New York City. About DCAT Week DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association

DCAT  March 23-26, 2020, New York City Read More »

CBL Approved by EMA & FDA

CBL, the “Peptide Innovators” was recently  inspected both by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA).  Approvals were received from both agencies for the API manufacturing of octreotide.  This drug is used in the treatment of various cancers.

CBL Approved by EMA & FDA Read More »

CBL 2019 Meetings

CBL looks forward to meeting with you at the following events in 2019: FDA Generics Forum (Maryland) April 3-4 CPhI (Chicago, Booth 1646) April 30-May 2 TIDES (San Diego) May 20-23 APS (Monterey) June 22-27  (sponsor) Boulder Peptide Syposium (September 23-26) (Founding sponsor) CPhI  Worldwide (Frankfurt) November 5-7 Innovations forum 2019: Afternoon Session (Athens) November

CBL 2019 Meetings Read More »

CBL 2018 Meetings

CBL looks forward to meeting with you at the following events in 2018: • CPhI North America (Philadelphia, PA) April 24-26 • TIDES (Boston, MA) May 7-10 • European Peptide Society Symposium (Dublin, Ireland)Aug. 26-31st • Boulder Peptide Symposium (Boulder, CO) Sept. 24-27 • Peptide Therapeutics Symposium (San Diego, CA) October 25-26 • USP 5th

CBL 2018 Meetings Read More »

CBL 2017 Meetings

CBL looks forward to meeting with you at the following 2017 meetings: Tides (San Diego, CA) April 30-May 3, 2017 Presenting: “Implementation of  Appropriate cGMP’s for Preclinical through Commercial Drug Substance: An Industry Perspective”. American Peptide Society Symposium (Whistler, Canada),  Sponsor, June 17-22, 2017 Presenting:”Convergent Synthesis of a Triple Bridged Insulin Derivative”. Boulder Peptide Symposium, (Boulder,

CBL 2017 Meetings Read More »